• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    7/10/23 1:50:32 PM ET
    $STRC
    $TCBP
    $TEAF
    $TGL
    Wholesale Distributors
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $STRC alert in real time by email

     

    On Monday, 65 companies hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).
    • The smallest company in terms of market cap to set a new 52-week low was Biodexa Pharmaceuticals (NASDAQ:BDRX).
    • Tivic Health Systems (NASDAQ:TIVC) shares traded down 40.69% to reach its 52-week low, making it the biggest loser.
    • Chijet Motor Co (NASDAQ:CJET) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • Bristol-Myers Squibb (NYSE:BMY) shares fell to $62.30 on Monday, setting a new 52-week low with a shift of down 0.54%.
    • Humana (NYSE:HUM) shares reached a new 52-week low of $427.21 on Monday morning, moving up 0.06%.
    • Amcor (NYSE:AMCR) stock hit a new 52-week low of $9.48. The stock was down 3.77% on the session.
    • FMC (NYSE:FMC) stock hit $88.80 on Monday morning, setting a new 52-week low for a change of down 14.62%.
    • KT (NYSE:KT) shares fell to $11.10 on Monday, setting a new 52-week low with a shift of up 0.04%.
    • UGI (NYSE:UGI) shares were down 0.81% for the day, having made a 52-week low of $25.69.
    • Clearway Energy (NYSE:CWEN) shares moved down 0.29% on Monday to hit a new 52-week low of $27.38, drifting down 0.29%.
    • California Water Servs Gr (NYSE:CWT) shares set a new yearly low of $49.27 this morning. The stock was down 0.37% on the session.
    • SunPower (NASDAQ:SPWR) stock hit a new 52-week low of $8.99. The stock was up 1.49% on the session.
    • Northwest Natural Hldg (NYSE:NWN) shares reached a new 52-week low of $41.64 on Monday morning, moving up 0.12%.
    • Duckhorn Portfolio (NYSE:NAPA) stock broke to a new 52-week low of $12.54 on Monday. Shares of the company traded down 1.41%.
    • Kenon Hldgs (NYSE:KEN) stock achieved a new 52-week low on Monday morning, hitting $22.85 and moving down 2.52%.
    • Enanta Pharma (NASDAQ:ENTA) shares were up 1.69% for the day, having made a 52-week low of $19.29.
    • Chijet Motor Co (NASDAQ:CJET) stock achieved a new 52-week low on Monday morning, hitting $2.31 and moving 0.0% (flat).
    • First Foundation (NASDAQ:FFWM) shares made a new 52-week low of $3.75 on Monday. The stock was down 0.52% for the day.
    • Douglas Elliman (NYSE:DOUG) shares were up 5.6% for the day, having made a 52-week low of $2.07.
    • Tortoise Essential Assets (NYSE:TEAF) shares moved down 0.32% on Monday to hit a new 52-week low of $12.20, drifting down 0.32%.
    • Delaware Inv Natl Muni (AMEX:VFL) shares fell to $9.85 on Monday, setting a new 52-week low with a shift of down 0.2%.
    • OptiNose (NASDAQ:OPTN) stock hit $1.05 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Cherry Hill Mortgage (NYSE:CHMI) shares fell to $4.33 on Monday, setting a new 52-week low with a shift of down 0.23%.
    • Meihua Intl Medical Techs (NASDAQ:MHUA) shares moved up 1.24% on Monday to hit a new 52-week low of $2.38, drifting up 1.24%.
    • Jerash Holdings (US) (NASDAQ:JRSH) stock dropped to a yearly low on Monday of $3.64. Shares traded down 1.35%.
    • 22nd Century Group (NASDAQ:XXII) shares hit a yearly low of $2.42. The stock was down 7.47% on the session.
    • Interactive Strength (NASDAQ:TRNR) shares fell to $2.49 on Monday, setting a new 52-week low with a shift of up 3.44%.
    • Sarcos Technology (NASDAQ:STRC) stock hit $1.46 on Monday morning, setting a new 52-week low for a change of down 6.23%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.27. The stock was down 7.64% on the session.
    • Psychemedics (NASDAQ:PMD) shares set a new 52-week low of $4.19. The stock traded up 0.46%.
    • Tattooed Chef (NASDAQ:TTCF) shares reached a new 52-week low of $0.21 on Monday morning, moving down 11.54%.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.61 on Monday morning, setting a new 52-week low for a change of down 2.25%.
    • Cineverse (NASDAQ:CNVS) stock hit a yearly low of $1.53. The stock was down 3.4% for the day.
    • Treasure Global (NASDAQ:TGL) shares fell to $0.90 on Monday, setting a new 52-week low with a shift of down 3.29%.
    • Avalon Globocare (NASDAQ:ALBT) stock set a new 52-week low of $1.19 on Monday, moving up 6.19%.
    • ABVC BioPharma (NASDAQ:ABVC) shares set a new 52-week low of $0.44. The stock traded down 2.06%.
    • FOXO Technologies (AMEX:FOXO) shares moved down 7.27% on Monday to hit a new 52-week low of $0.18, drifting down 7.27%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Monday of $0.70. Shares traded down 3.1%.
    • T Stamp (NASDAQ:IDAI) shares were down 5.37% for the day, having made a 52-week low of $0.96.
    • iSun (NASDAQ:ISUN) shares set a new 52-week low of $0.37. The stock traded down 1.19%.
    • Ault Alliance (AMEX:AULT) shares fell to $4.86 on Monday, setting a new 52-week low with a shift of down 1.78%.
    • Enservco (AMEX:ENSV) stock broke to a new 52-week low of $0.29 on Monday. Shares of the company traded up 2.07%.
    • OceanPal (NASDAQ:OP) stock broke to a new 52-week low of $1.26 on Monday. Shares of the company traded down 7.56%.
    • SuperCom (NASDAQ:SPCB) shares made a new 52-week low of $0.92 on Monday. The stock was up 0.36% for the day.
    • Ra Medical Systems (AMEX:RMED) shares set a new 52-week low of $0.70. The stock traded down 5.47%.
    • Gaucho Group Holdings (NASDAQ:VINO) shares moved up 1.99% on Monday to hit a new 52-week low of $0.50, drifting up 1.99%.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a new 52-week low of $1.05. The stock was down 5.65% on the session.
    • Ucommune International (NASDAQ:UK) shares made a new 52-week low of $0.50 on Monday. The stock was up 1.63% for the day.
    • G Medical Innovations (NASDAQ:GMVD) shares made a new 52-week low of $0.32 on Monday. The stock was up 1.73% for the day.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new 52-week low of $0.43. The stock traded down 1.97%.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 2.76% for the day, having made a 52-week low of $3.76.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $STRC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRC
    $TCBP
    $TEAF
    $TGL

    CompanyDatePrice TargetRatingAnalyst
    Pfizer Inc.
    $PFE
    12/2/2025$26.00Neutral
    Citigroup
    Enanta Pharmaceuticals Inc.
    $ENTA
    11/14/2025Overweight
    Analyst
    Pfizer Inc.
    $PFE
    11/13/2025$30.00Sector Outperform
    Scotiabank
    Bristol-Myers Squibb Company
    $BMY
    11/13/2025$45.00Sector Perform
    Scotiabank
    FMC Corporation
    $FMC
    11/11/2025$16.00Equal Weight
    Wells Fargo
    Cherry Hill Mortgage Investment Corporation
    $CHMI
    11/6/2025$2.75Mkt Perform → Mkt Outperform
    Citizens JMP
    First Foundation Inc.
    $FFWM
    11/3/2025$6.75Neutral → Overweight
    Piper Sandler
    FMC Corporation
    $FMC
    10/31/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $STRC
    $TCBP
    $TEAF
    $TGL
    SEC Filings

    View All

    SunPower Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SunPower Inc. (0001838987) (Filer)

    12/4/25 4:06:02 PM ET
    $SPWR
    Semiconductors
    Technology

    SEC Form 425 filed by First Foundation Inc.

    425 - First Foundation Inc. (0001413837) (Subject)

    12/4/25 10:15:54 AM ET
    $FFWM
    Major Banks
    Finance

    FMC Corporation filed SEC Form 8-K: Leadership Update

    8-K - FMC CORP (0000037785) (Filer)

    12/3/25 4:28:59 PM ET
    $FMC
    Major Chemicals
    Industrials

    $STRC
    $TCBP
    $TEAF
    $TGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on Pfizer with a new price target

    Citigroup resumed coverage of Pfizer with a rating of Neutral and set a new price target of $26.00

    12/2/25 8:29:06 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Analyst initiated coverage on Enanta Pharmaceuticals

    Analyst initiated coverage of Enanta Pharmaceuticals with a rating of Overweight

    11/14/25 11:26:32 AM ET
    $ENTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scotiabank initiated coverage on Pfizer with a new price target

    Scotiabank initiated coverage of Pfizer with a rating of Sector Outperform and set a new price target of $30.00

    11/13/25 9:16:05 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dietze Jane A bought $104,808 worth of Series A Perpetual Stretch Preferred Stock (1,100 units at $95.28), increasing direct ownership by 73% to 2,600 units (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    11/25/25 4:30:14 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    Director Long Nicholas T. bought $85,374 worth of Ordinary Shares (10,000 units at $8.54), increasing direct ownership by 19% to 62,911 units (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    11/14/25 4:03:10 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Director Raines John Mitchell bought $96,390 worth of shares (7,000 units at $13.77), increasing direct ownership by 103% to 13,784 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    11/14/25 9:19:38 AM ET
    $FMC
    Major Chemicals
    Industrials

    $STRC
    $TCBP
    $TEAF
    $TGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bristol Myers Squibb's Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

    In the MZL cohort of TRANSCEND FL, Breyanzi delivered deep and durable responses in 95.5% of patients while demonstrating a consistent safety profile Breyanzi is now the only CAR T cell therapy approved by the FDA for five cancer types, the most of any CD19-directed CAR T cell therapy Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) who have received at least two prior lines of systemic therapy. Breyanzi is adm

    12/4/25 8:15:00 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SuperCom Wins New Electronic Monitoring Contract in Texas, Expands U.S. Footprint into 14th State

    Juvenile probation agency selects SuperCom to replace incumbent vendor and modernize offender monitoring programs TEL AVIV, Israel, Dec. 4, 2025 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that it has secured a new electronic monitoring (EM) contract with a juvenile probation agency in the state of Texas. This award marks SuperCom's first contract in Texas and continues the Company's nationwide expansion, now reaching 14 U.S. states since mid-2024.     The agency, which previously relied on a long-standing incumbent provider, selected SuperCom to modernize its offender supervision capabi

    12/4/25 9:00:00 AM ET
    $SPCB
    Semiconductors
    Technology

    Strategy and HCLTech Partner to Advance Data Analytics at Scale with AI-driven Solutions

    Collaboration to Scale Deployment of Strategy Mosaic, the AI-Powered Universal Semantic Layer, for Global Enterprise Clients Strategy (NASDAQ:MSTR), the world's largest independent publicly traded enterprise analytics company (formerly MicroStrategy), and HCLTech, a leading global technology company, today announced a strategic partnership to accelerate the global adoption and deployment of Strategy Mosaic, Strategy's AI-powered Universal Semantic Layer, for global enterprise clients. As part of the collaboration, Strategy has named HCLTech a preferred enterprise solution and professional services partner. HCLTech will leverage its extensive consulting services and AI-intrinsic technology

    12/4/25 9:00:00 AM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rahman Jill A sold $35,005 worth of Ordinary Shares (4,148 units at $8.44), decreasing direct ownership by 5% to 82,535 units (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    12/4/25 4:04:24 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Director Carter Susan K sold $51,123 worth of Ordinary Shares (6,058 units at $8.44), decreasing direct ownership by 8% to 71,302 units (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    12/4/25 4:02:48 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    SEC Form 4 filed by Enanta Pharmaceuticals Inc.

    4 - ENANTA PHARMACEUTICALS INC (0001177648) (Issuer)

    12/3/25 5:09:07 PM ET
    $ENTA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Financials

    Live finance-specific insights

    View All

    Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, December 16, 2025. The purpose of the call is to provide Pfizer's full-year 2026 financial guidance. To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call. You can also listen to the conference call by dialing either 800-456-4352 in the United States and Canada or 785-424-1086 outside of the United States

    12/1/25 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Strategy Announces Establishment of $1.44 Billion USD Reserve and Updates FY 2025 Guidance

      Strategy Inc (NASDAQ:STRF, LuxSE: STRE)) today announced the establishment of a US dollar reserve ("USD Reserve") of $1.44 billion and updates to its assumptions underlying its previously issued forward guidance and bitcoin key performance indicator ("KPI") targets for the fiscal year ending December 31, 2025, which were published on October 30, 2025. Establishment of USD Reserve Strategy today announced that it has established a USD Reserve of $1.44 billion to support the payment of dividends on its preferred stock and interest on its outstanding indebtedness ("Dividends"). The USD Reserve was funded using proceeds from the sale of shares of class A common stock under Strategy's at-th

    12/1/25 8:00:00 AM ET
    $MSTR
    $STRC
    Computer Software: Prepackaged Software
    Technology
    Wholesale Distributors
    Industrials

    UGI Reports Strong Fiscal 2025 Results

    Issues Fiscal 2026 Guidance UGI Corporation (NYSE:UGI) today reported financial results for the fiscal year ended September 30, 2025 and provided guidance for fiscal year 2026. HEADLINES GAAP net income of $678 million and adjusted net income of $728 million compared to GAAP net income of $269 million and adjusted net income of $658 million in the prior year. GAAP diluted earnings per share ("EPS") of $3.09 and adjusted diluted EPS of $3.32 compared to GAAP diluted EPS of $1.25 and adjusted diluted EPS of $3.06 in the prior year. Reportable segments earnings before interest expense and income tax1 ("EBIT") of $1,176 million compared to $1,178 million in the prior year. Deliv

    11/20/25 5:30:00 PM ET
    $UGI
    Natural Gas Distribution
    Utilities

    $STRC
    $TCBP
    $TEAF
    $TGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Leadership Updates

    Live Leadership Updates

    View All

    Kenon Holdings Reports Q3 2025 Results and Additional Updates

    SINGAPORE, Dec. 3, 2025 /PRNewswire/ -- Kenon Holdings Ltd. (NYSE:KEN) (TASE: KEN) ("Kenon") announces its results for Q3 2025 and additional updates. Q3 and Recent Highlights Kenon In November 2025, Kenon sold a small portion of its OPC shares for gross proceeds of NIS 340 million (approximately $100 million).OPC In October 2025, OPC announced the financial closing and commencement of construction of the Basin Ranch Project, a gas-fired power plant project in Texas with an estimated 1.35 GW capacity (as described below), and CPV's entry into an agreement to acquire the remaining 30% interest in the Basin Ranch Project.In October 2025, OPC announced that CPV had entered into an agreement t

    12/3/25 8:36:00 AM ET
    $KEN
    Electric Utilities: Central
    Utilities

    SunPower Closes $37.5M Ambia Solar Acquisition

    OREM, Utah, Nov. 24, 2025 (GLOBE NEWSWIRE) -- SunPower Inc. (herein "SunPower," the "Company," or Nasdaq: "SPWR") a solar technology, services, and installation company, today announced that it has closed its $37.5 million strategic acquisition of Ambia Solar ("Ambia") to create the No. 5 U.S. residential solar company, based on Ohm Analytics rankings. SunPower CEO T.J. Rodgers said, "Due to our quick closing of the acquisition, we are raising our Q4'25 quarterly revenue estimate to $88 million. We still expect record operating income in Q4'25 and at least $2.0 million in operating income in Q1'26, the winter solar "down" quarter. In addition, and equally important, the acquisition brings

    11/24/25 8:00:00 AM ET
    $CSLR
    $SPWR
    Semiconductors
    Technology

    Trust Stamp selected for Trust Village 2026 Programme in Switzerland

    Atlanta, GA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI): Trust Stamp, a global provider of AI-powered software solutions focused on identity and trust, today announced its selection for the 2026 Trust Village Incubator, an initiative powered by EPFL Innovation Park, Trust Valley, SICPA and Canton de Vaud.The selection recognizes Trust Stamp's pioneering work in privacy-preserving identity technology, particularly its latest innovation, StableKey™, built upon the company's patented Stable IT2 cryptosystem. The StableKey solution introduces a groundbreaking approach to biometric authentication by enabling secure identity verification without storing any sensitive biometric d

    11/20/25 9:35:00 AM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology